Infectious endocarditis – diagnostics and guidelines

Czech version

Authors: J. Přeček; M. Hutyra; J. Látal; F. Kováčik; M. Táborský
Authors‘ workplace: I. interní klinika – kardiologická LF UP a FN Olomouc
Published in: Kardiol Rev Int Med 2015, 17(4): 307-314
Category: Cardiology Review

Overview

Despite the progress in diagnostics and treatment, infectious endocarditis continues to be a severe disease where the incidence is not decreasing. The nature of the disease in developed countries has been changing due to aging of the population, an increasing number of comorbidities and changing risk factors. The European Society of Cardiology has published new guidelines for the diagnostics and treatment of infectious endocarditis. These recommendations introduce changes regarding treatment organisation and diagnostic criteria for patients with infectious endocarditis. This article characterises infectious endocarditis in current conditions and discusses its diagnostics, therapy and prophylaxis. Infectious endocarditis in patients with intracardiac electronic devices is mentioned as a specific type of the disease.

Keywords:
infectious endocarditis – diagnostics – guidelines – cardiac device related infectious endocarditis

Sources

1. Habib G, Lancellotti P, Antunes MJ et al. 2015 ESC Guidelines for the management of infective endokarditis. The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC) Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J2015; pii: ehv319. doi: 10.1093/ eurheartj/ ehv319.

2. Murdoch DR, Corey GR, Hoen B et al. The International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 2009; 169: 463–473. doi: 10.1001/ archinternmed.2008.603.

3. Cahill JT, Prendergast BD. Infective Endocarditis. Lancet 2015; pii: S0140-6736(15)00067-7. doi: 10.1016/ S0140-6736(15)00067-7.

4. Yew HS, Murdoch DR. Global trends in infective endokarditis epidemiology. Curr Infect Dis Rep 2012; 14: 367–372. doi: 10.1007/ s11908-012-0265-5.

5. Werdan K, Dietz S, Lofflër B et al. Mechanisms of infective endocarditis: pathogen-host interaction and risk states. Nat Rev Cardiol 2014; 11: 35–50. doi: 10.1038/ nrcardio.2013.174.

6. Daniel WG, Flachskampf FA. Infective Endocarditis. In: Camm AJ, Lüscher TF, Serruys PW. The ESC Testbook of Cardiovascular Medicine. Oxford: Oxford University Press 2009: 819–833.

7. Beneš J, Gregor P, Mokráček P. Infekční endokarditida: Doporučené postupy diagnostiky, léčby, dispenzarizace a profylaxe. Cor Vasa 2007; 49: Kardio.

8. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med 1994; 96: 200–209.

9. Li JS, Sexton DJ, Mick N et al. Proposed modifications to the Duke criteria for the diagnosis if infective endocarditis. Clin Infect Dis 2000; 30: 633–638.

10. Habib G, Derumeaux G, Avierinos JF et al. Value and limitations of the Duke criteria for the diagnosis of infective endocarditis. J Am Coll Cardiol 1999; 33: 2023–2029.

11. Vieira ML, Grinberg M, Pomerantzeff PM et al. Repeated echocardiographic examinations of patients with suspected infective endocarditis. Heart 2004; 90: 1020–1024.

12. Berdejo J, Shibayama K, Harada K et al. Evaluation of vegetation size and its relationship with embolism in infective endocarditis: a real-time 3-dimensional transesophageal echocardiography study. Circ Cardiovasc Imaging 2014; 7: 149–154. doi: 10.1161/ CIRCIMAGING.113.000938.

13. Botelho-Nevers E, Thuny F, Casalta JP et al. Dramatic reduction in infective endocarditis-related mortality with a management-based approach. Arch Intern Med 2009; 169: 1290–1298. doi: 10.1001/ archinternmed.2009.192.

14. Prendergast BD, Tornos P. Surgery for infective endocarditis: who and when? Circulation 2010; 121: 1141–1152. doi: 10.1161/ CIRCULATIONAHA.108.773598.

15. Mallhotra A, Rayner J, Williams TM et al. Infective endocarditis: therapeutic options and indications for surgery. Curr Cardiol Rep 2014; 16: 464–469. doi: 10.1007/s11886-014-0464-9.

16. Kupferwasser LI, Yeaman MR, Shapiro SM et al. Acetylsalicylic acid reduces vegetation bacterial density, hematogenous bacterial dissemination, and frequency of embolic events in experimental Staphylococcus aureus endocarditis through antiplatelet and antibacterial effects. Circulation 1999; 99: 2791–2797.

17. Chan KL, Dumesnil JG, Cujec B et al. A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis. J Am Coll Cardiol 2003; 42: 775–780.

18. Duval X, Leport C. Prophylaxis of infective endocarditis: current tendencies, continuing controversies. Lancet Infect Dis 2008; 8: 225–232. doi: 10.1016/ S1473-3099(08)70064-1.

19. Johansen JB, Jorgensen OD, Moller M et al. Infection after pacemaker implantation: infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients. Eur Heart J 2011; 32: 991–998. doi: 10.1093/ eurheartj/ ehq497.

20. Uslan DZ, Sohail MR, St Sauver JL et al. Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med 2007; 167: 669–675.

21. Lekkerkerker JC, van Nieuwkoop C, Trines SA et al. Risk factors and time delay associated with cardiac device infections: Leiden device registry. Heart 2009; 95: 715–720. doi: 10.1136/ hrt.2008.151985.

22. Baddour LM, Bettmann MA, Bolger AF et al. Nonvalvular, cardiovascular device-related infections. Circulation 2003; 108: 2015–2031.

23. Sandoe JA, Barlow G, Chambers JB et al. Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British Heart Rhythm Society (BHRS), British Cardiovascular Society (BCS), British Heart Valve Society (BHVS) and British Society for Echocardiography (BSE). J Antimicrob Chemother 2015; 70: 325–359. doi: 10.1093/ jac/ dku383.

24. Beneš J. Mění se incidence infekční endokarditidy? Interv Akut Kardiol 2010; 9: 231–232.

25. Trubil M, Němec P. Infekční endokarditida. Interv Akut Kardiol 2007; 6(4): 139–143.